Sign in

CIK 0001710340 · Non-accelerated filer<br>Smaller reporting company

Eton Pharmaceuticals, Inc.

Sign in to watch
Ticker
ETON
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
371858472
Phone
(847) 787-7361
Business address
21925 W. FIELD PARKWAY, SUITE 235, DEER PARK, IL, 60010-7278
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$19,432,082
in 7 filings

Net −$19,432,082. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. BRYNJELSEN SEAN −$6.1M President & CEO sold 9% of stake
  2. MAIER PAUL V −$5.9M Director sold 63% of stake
  3. CASAMENTO CHARLES J −$5.3M Director sold 100% of stake
  4. Krempa David −$1.9M Chief Business Officer sold 40% of stake
  5. Erdogan-Trinkaus Ipek −$236K Chief Commercial Officer sold 46% of stake
Date Insider Transaction Shares Price Value Owned after
2024-02-13 RIEDEL NORBERT G Director Grant or award · Stock Option (Right to buy) +30,000 164,555
2023-03-03 RIEDEL NORBERT G Director Grant or award · Stock Option (Right to buy) +25,000 134,555
2023-03-03 CASAMENTO CHARLES J Director Grant or award · Stock Option (Right to buy) +25,000 134,555
2023-03-03 MAIER PAUL V Director Grant or award · Stock Option(Right to buy) +25,000 134,555
2023-03-03 Adams Jennifer McKie Director Grant or award · Stock Option (Right to buy) +25,000 103,133
2023-03-03 Gruber James R. Chief Financial Officer Grant or award · Stock Option (right to buy) +100,086 200,086
2023-03-03 BRYNJELSEN SEAN President & CEO Grant or award · Stock Option (Right to buy) +350,381 1,951,881
2022-09-22 BRYNJELSEN SEAN Chief Executive Officer Purchase +10,000 $2.10 $21K 1,040,000
2022-07-12 BRYNJELSEN SEAN Chief Executive Officer Grant or award · Restricted Stock Units +110,000 110,000
2022-07-12 Gruber James R. Chief Financial Officer Grant or award · Restricted Stock Units +40,000 40,000
2022-02-07 Adams Jennifer McKie Director Grant or award · Stock Option (Right to buy) +50,000 78,133
2022-02-07 MAIER PAUL V Director Grant or award · Stock Option(Right to buy) +50,000 109,555
2022-02-07 RIEDEL NORBERT G Director Grant or award · Stock Option (Right to buy) +50,000 109,555
2022-02-07 Troutman William Wilson CFO and Secretary Grant or award · Stock Option (Right to buy) +15,000 671,200
2022-02-07 CASAMENTO CHARLES J Director Grant or award · Stock Option (Right to buy) +50,000 109,555
2022-02-07 BRYNJELSEN SEAN President & CEO Grant or award · Stock Option(Right to buy) +416,500 1,601,500
2021-11-17 Opaleye Management Inc. 10% owner Sale −25,000 $4.67 $117K 2,375,000
2021-11-16 Opaleye Management Inc. 10% owner Sale −11,500 $4.86 $56K 2,400,000
2021-11-16 Opaleye Management Inc. 10% owner Sale −938 $4.86 $5K 85,000
2021-11-15 Opaleye Management Inc. 10% owner Sale −2,500 $4.80 $12K 2,411,500

Page 9 of 13 · 249 trades